Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58.
Small AM, Berg DD, Raz I, Jarolim P, Goodrich EL, Moura FA, Mosenzon O, Cahn A, Bhatt DL, Dwyer JP, Leiter LA, Wilding JPH, Gause-Nilsson I, Sabatine MS, Morrow DA, Wiviott SD
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.